IDEXX Laboratories (IDXX) is a publicly traded Healthcare sector company. As of August 15, 2026, IDXX trades at $557.10 with a market cap of $44.95B and a P/E ratio of 38.88. IDXX moved -2.80% today. Year to date, IDXX is -17.77%; over the trailing twelve months it is -15.75%. Its 52-week range spans $356.14 to $769.98. Analyst consensus is buy with an average price target of $696.00. Rallies surfaces IDXX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks IDXX insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $557.10 |
| Market Cap | $44.95B |
| P/E Ratio | 38.88 |
| EPS | $14.33 |
| Dividend Yield | 0.00% |
| 52-Week High | $769.98 |
| 52-Week Low | $356.14 |
| Volume | 353.49K |
| Avg Volume | 0 |
| Revenue (TTM) | $4.55B |
| Net Income | $1.14B |
| Gross Margin | 62.45% |
6 analysts cover IDXX: 0 strong buy, 3 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $696.00.